- A-Medicare transforms and future-proof processes, services, and businesses by adopting newer digital technology, singular and blockchain databases, machine learning, big data, patient data analytics, and artificial intelligence to gain accurate insight and outcomes into drug usage, diagnosis, healthcare, and patient health lifestyles.
- A software and hardware infrastructure will be developed to perform command, control, and continuous monitoring (C3M) of connected network of client hospital operations and use Internet of Things (IoT) and bionic devices worn by patients to track and analyze users’ health data. The C3M can drill down real-time data of patients such as location, chart, doctor, provider, and medical insurance when first symptoms appear and alert medical staff and contracted medical professionals.
- Develop an Internet of Things (IoT) devices (similar to Fitbit or Apple Watch), and bionic nano devices such as liquid chip that is embedded into a patient skin whose electrical power is harvested from the skin temperature. These nano devices securely store selected patient 'diary' data such as PII and PHI. Once the nano device or IoT is near the vicinity of a secure Wi-Fi network, it will auto connect and new data are uploaded into a central database. The central database is continuously updated by the patient's daily activities such as exercise, drug, or medication usage, diet, and other behavioral data.
- Use of the bionic and wearable devices, employ smart software tools and notification that are linked to the data warehouse, big data, and web intelligence to identify potential failures of the devices (IoT) and changes in the patient's medical data long before a symptom occurs.
- Apply cybersecurity policy using blockchains, immutable ledgers, and hash techniques on selected Personally Identifiable Information (PII), Protected Health Information (PHI), diagnosis, and DNA to comply with HIPAA and other governing bodies.